Cantel Medical (CMN) 73.47 $CMN
Company News for June 09, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 9:10AM CDT
Companies in the News are: PLAY,PAY,CMN,GEF
PLAY: 47.05 (+0.29), PAY: 19.60 (-0.06), GEF: 39.98 (+0.14), CMN: 73.47 (-0.11)
Cantel Medical Announces Record Financial Results for Third Quarter 2016
PR Newswire - Wed Jun 08, 7:00AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) today reported US GAAP net income of $14,019,000, or $0.34 per diluted share, on a 22.8% increase in sales to a record $173,703,000 for the third quarter ended April 30, 2016. This compares with US GAAP net income of $12,356,000 or $0.30 per diluted share, on sales of $141,508,000 for the third quarter ended April 30, 2015. For the nine months ended April 30, 2016, the Company reported record US GAAP net income of $43,662,000, or $1.05 per diluted share on a 17.4% increase in sales to a record $485,753,000. This compares with US GAAP net income of $34,680,000, or $0.83 per diluted share, on sales of $413,749,000 for the nine months ended April 30, 2015.
CMN: 73.47 (-0.11)
Investor Calendar Invites You to the Cantel Medical Corp. Third Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, June 8, 2016
ACCESSWIRE - Tue Jun 07, 3:05PM CDT
LITTLE FALLS, NJ / ACCESSWIRE / June 7, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the third quarter 2016, to be held Wednesday, June 8, 2016 at 11:00 AM Eastern Time.
CMN: 73.47 (-0.11)
/C O R R E C T I O N -- Cantel Medical Corp./
PR Newswire - Thu Jun 02, 10:10AM CDT
In the news release, Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016, issued June 1, 2016 by Cantel Medical Corp. over PR Newswire, we are advised by the company that the conference call date in the first and second paragraph should be "Wednesday, June 8" rather than "Thursday, June 8" as originally issued inadvertently. The complete, corrected release follows:
CMN: 73.47 (-0.11)
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016
PR Newswire - Wed Jun 01, 10:04AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its third quarter ended April 30, 2016 on Thursday, June 8 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 73.47 (-0.11)
Cantel Medical to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Mon May 23, 11:03AM CDT
Cantel Medical Corp. (NYSE:CMN) announced today that Jorgen B. Hansen, President and CEO-elect, will be presenting at the Jefferies 2016 Global Healthcare Conference at the Grand Hyatt in New York City. The formal presentation is scheduled for Tuesday, June 7, 2016 at 11:30 a.m. EDT. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 73.47 (-0.11)
Cantel Medical To Present At The 15th Annual Needham & Company Healthcare Conference
PR Newswire - Wed Mar 30, 9:44AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and Chief Operating Officer, will be presenting at the 15th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 13, 2016 at 12:10 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 73.47 (-0.11)
Cantel Medical Subsidiary, Mar Cor Purification, Launches New Dialysis Water Transport System
PR Newswire - Wed Mar 30, 7:00AM CDT
Mar Cor Purification announced the release of its new ROVER(TM) Portable Dialysis Water Transport System, the first all-plastic, dialysis water cart designed specifically for the hospital environment. The cart was developed to streamline the transport of water purification equipment used in acute hemodialysis procedures and to eliminate the possibility of deterioration associated with metal carts. The ROVER cart improves the safety and efficiency of delivering a dialysis water treatment system within the hospital. All components are fully integrated into the cart system, making the monitoring of key parameters and execution of daily procedures more convenient. The ROVER System has smooth plastic surfaces, which allow for easy cleaning and disinfection, thereby protecting the patient from infection.
CMN: 73.47 (-0.11)
Cantel Medical Announces CEO Succession
PR Newswire - Thu Mar 17, 8:43AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that consistent with its long-term succession plan, Jorgen B. Hansen, Cantel's President and Chief Operating Officer will become President and Chief Executive Officer as well as become a member of the Board of Directors on August 1, 2016. Andrew A. Krakauer will step down from the CEO role and as a Director on July 31, 2016 and serve as a Senior Advisor until October 15, 2016.
CMN: 73.47 (-0.11)
Cantel Medical Up on Q2 Earnings Beat, Sales Improvement
Zacks Equity Research - Zacks Investment Research - Mon Mar 14, 8:50AM CDT
Share price of Cantel Medical (CMN) rallied 3.7% ($2.59) to close at $72.21 on Mar 11, following stellar second-quarter 2016 results
ABMD: 102.87 (+0.34), LMNX: 20.41 (+0.03), CRY: 12.03 (+0.15), CMN: 73.47 (-0.11)
Cantel posts 2Q profit
Automated Insights - Thu Mar 10, 7:07AM CST
LITTLE FALLS, N.J. (AP) _ Cantel Medical Corp. (CMN) on Thursday reported fiscal second-quarter profit of $15.4 million.
CMN: 73.47 (-0.11)
Cantel Medical Reports Record Results for the Second Quarter Ended January 31, 2016
PR Newswire - Thu Mar 10, 7:00AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) reported record US GAAP net income of $15,389,000, or $0.37 per diluted share, on a 16.9% increase in sales to a record $158,271,000 for the second quarter ended January 31, 2016. This compares with net income of $11,085,000 or $0.27 per diluted share, on sales of $135,430,000 for the second quarter ended January 31, 2015. For the six months ended January 31, 2016, the Company reported record US GAAP net income of $29,643,000, or $0.71 per diluted share on a 14.6% increase in sales to a record $312,050,000. This compares with net income of $22,324,000, or $0.54 per diluted share, on sales of $272,241,000 for the six months ended January 31, 2015.
CMN: 73.47 (-0.11)
Investor Calendar Invites You to the Cantel Medical Corp. Second Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, March 10, 2016
ACCESSWIRE - Wed Mar 09, 3:05PM CST
LITTLE FALLS, NJ / ACCESSWIRE / March 9, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Thursday, March 10, 2016 at 11:00 AM Eastern Time.
CMN: 73.47 (-0.11)
Global Medical Sterilization Equipment & Services Market 2016-2021 - Key Players are 3M, Cantel Medical Corporation & Synergy Health PLC - Research and Markets
BusinessWire - Mon Mar 07, 8:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/dzp6cb/global_medical) has announced the addition of the "Global Medical Sterilization Equipment and Services Market: Trends, Opportunities and Forecasts (2016-2021)" report to their offering.
CMN: 73.47 (-0.11)
Cantel Medical Acquisition Suite Accretive, Adds NAMSA Unit
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 11:50AM CST
Cantel Medical (CMN) recently completed the previously announced acquisition of NAMSA's Sterility Assurance Monitoring Products division.
ABMD: 102.87 (+0.34), LMNX: 20.41 (+0.03), CRY: 12.03 (+0.15), CMN: 73.47 (-0.11)
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2016
PR Newswire - Thu Mar 03, 7:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its second quarter ended January 31, 2016 on Thursday, March 10 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 73.47 (-0.11)
Cantel Medical To Present At The RBC Capital Markets' 2016 Healthcare Conference
PR Newswire - Wed Feb 10, 10:49AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the RBC Capital Markets' 2016 Healthcare Conference at The New York Palace Hotel. The formal presentation is scheduled for Wednesday, February 24, 2016 at 9:30 a.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 73.47 (-0.11)
Cantel Medical To Acquire NAMSA's Sterility Assurance Products Division
PR Newswire - Wed Feb 03, 6:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN), has entered into a definitive agreement with North American Science Associates, Inc. (NAMSA) to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million. The Sterility Assurance Monitoring Products division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Cantel's Healthcare Disposables segment.
CMN: 73.47 (-0.11)
Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Online Dialysis Water Catalog
PR Newswire - Tue Jan 19, 7:30AM CST
Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog - 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience.
CMN: 73.47 (-0.11)
Uptrend Call Working As Cantel Medical Stock Rises 18.8% (CMN)
Comtex SmarTrend(R) - Tue Dec 29, 9:39AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on September 17th, 2015 at $53.37. In approximately 3 months, Cantel Medical has returned 18.77% as of today's recent price of $63.39.
CMN: 73.47 (-0.11)
Company News for June 09, 2016
Zacks Equity Research - Zacks Investment Research - Thu Jun 09, 9:10AM CDT
Companies in the News are: PLAY,PAY,CMN,GEF
PLAY: 47.05 (+0.29), PAY: 19.60 (-0.06), GEF: 39.98 (+0.14), CMN: 73.47 (-0.11)
Cantel Medical Announces Record Financial Results for Third Quarter 2016
PR Newswire - Wed Jun 08, 7:00AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) today reported US GAAP net income of $14,019,000, or $0.34 per diluted share, on a 22.8% increase in sales to a record $173,703,000 for the third quarter ended April 30, 2016. This compares with US GAAP net income of $12,356,000 or $0.30 per diluted share, on sales of $141,508,000 for the third quarter ended April 30, 2015. For the nine months ended April 30, 2016, the Company reported record US GAAP net income of $43,662,000, or $1.05 per diluted share on a 17.4% increase in sales to a record $485,753,000. This compares with US GAAP net income of $34,680,000, or $0.83 per diluted share, on sales of $413,749,000 for the nine months ended April 30, 2015.
CMN: 73.47 (-0.11)
Investor Calendar Invites You to the Cantel Medical Corp. Third Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, June 8, 2016
ACCESSWIRE - Tue Jun 07, 3:05PM CDT
LITTLE FALLS, NJ / ACCESSWIRE / June 7, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the third quarter 2016, to be held Wednesday, June 8, 2016 at 11:00 AM Eastern Time.
CMN: 73.47 (-0.11)
/C O R R E C T I O N -- Cantel Medical Corp./
PR Newswire - Thu Jun 02, 10:10AM CDT
In the news release, Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016, issued June 1, 2016 by Cantel Medical Corp. over PR Newswire, we are advised by the company that the conference call date in the first and second paragraph should be "Wednesday, June 8" rather than "Thursday, June 8" as originally issued inadvertently. The complete, corrected release follows:
CMN: 73.47 (-0.11)
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April 30, 2016
PR Newswire - Wed Jun 01, 10:04AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its third quarter ended April 30, 2016 on Thursday, June 8 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 73.47 (-0.11)
Cantel Medical to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Mon May 23, 11:03AM CDT
Cantel Medical Corp. (NYSE:CMN) announced today that Jorgen B. Hansen, President and CEO-elect, will be presenting at the Jefferies 2016 Global Healthcare Conference at the Grand Hyatt in New York City. The formal presentation is scheduled for Tuesday, June 7, 2016 at 11:30 a.m. EDT. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 73.47 (-0.11)
Cantel Medical To Present At The 15th Annual Needham & Company Healthcare Conference
PR Newswire - Wed Mar 30, 9:44AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and Chief Operating Officer, will be presenting at the 15th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 13, 2016 at 12:10 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 73.47 (-0.11)
Cantel Medical Subsidiary, Mar Cor Purification, Launches New Dialysis Water Transport System
PR Newswire - Wed Mar 30, 7:00AM CDT
Mar Cor Purification announced the release of its new ROVER(TM) Portable Dialysis Water Transport System, the first all-plastic, dialysis water cart designed specifically for the hospital environment. The cart was developed to streamline the transport of water purification equipment used in acute hemodialysis procedures and to eliminate the possibility of deterioration associated with metal carts. The ROVER cart improves the safety and efficiency of delivering a dialysis water treatment system within the hospital. All components are fully integrated into the cart system, making the monitoring of key parameters and execution of daily procedures more convenient. The ROVER System has smooth plastic surfaces, which allow for easy cleaning and disinfection, thereby protecting the patient from infection.
CMN: 73.47 (-0.11)
Cantel Medical Announces CEO Succession
PR Newswire - Thu Mar 17, 8:43AM CDT
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that consistent with its long-term succession plan, Jorgen B. Hansen, Cantel's President and Chief Operating Officer will become President and Chief Executive Officer as well as become a member of the Board of Directors on August 1, 2016. Andrew A. Krakauer will step down from the CEO role and as a Director on July 31, 2016 and serve as a Senior Advisor until October 15, 2016.
CMN: 73.47 (-0.11)
Cantel Medical Up on Q2 Earnings Beat, Sales Improvement
Zacks Equity Research - Zacks Investment Research - Mon Mar 14, 8:50AM CDT
Share price of Cantel Medical (CMN) rallied 3.7% ($2.59) to close at $72.21 on Mar 11, following stellar second-quarter 2016 results
ABMD: 102.87 (+0.34), LMNX: 20.41 (+0.03), CRY: 12.03 (+0.15), CMN: 73.47 (-0.11)
Cantel posts 2Q profit
Automated Insights - Thu Mar 10, 7:07AM CST
LITTLE FALLS, N.J. (AP) _ Cantel Medical Corp. (CMN) on Thursday reported fiscal second-quarter profit of $15.4 million.
CMN: 73.47 (-0.11)
Cantel Medical Reports Record Results for the Second Quarter Ended January 31, 2016
PR Newswire - Thu Mar 10, 7:00AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) reported record US GAAP net income of $15,389,000, or $0.37 per diluted share, on a 16.9% increase in sales to a record $158,271,000 for the second quarter ended January 31, 2016. This compares with net income of $11,085,000 or $0.27 per diluted share, on sales of $135,430,000 for the second quarter ended January 31, 2015. For the six months ended January 31, 2016, the Company reported record US GAAP net income of $29,643,000, or $0.71 per diluted share on a 14.6% increase in sales to a record $312,050,000. This compares with net income of $22,324,000, or $0.54 per diluted share, on sales of $272,241,000 for the six months ended January 31, 2015.
CMN: 73.47 (-0.11)
Investor Calendar Invites You to the Cantel Medical Corp. Second Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, March 10, 2016
ACCESSWIRE - Wed Mar 09, 3:05PM CST
LITTLE FALLS, NJ / ACCESSWIRE / March 9, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Thursday, March 10, 2016 at 11:00 AM Eastern Time.
CMN: 73.47 (-0.11)
Global Medical Sterilization Equipment & Services Market 2016-2021 - Key Players are 3M, Cantel Medical Corporation & Synergy Health PLC - Research and Markets
BusinessWire - Mon Mar 07, 8:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/dzp6cb/global_medical) has announced the addition of the "Global Medical Sterilization Equipment and Services Market: Trends, Opportunities and Forecasts (2016-2021)" report to their offering.
CMN: 73.47 (-0.11)
Cantel Medical Acquisition Suite Accretive, Adds NAMSA Unit
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 11:50AM CST
Cantel Medical (CMN) recently completed the previously announced acquisition of NAMSA's Sterility Assurance Monitoring Products division.
ABMD: 102.87 (+0.34), LMNX: 20.41 (+0.03), CRY: 12.03 (+0.15), CMN: 73.47 (-0.11)
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2016
PR Newswire - Thu Mar 03, 7:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its second quarter ended January 31, 2016 on Thursday, March 10 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
CMN: 73.47 (-0.11)
Cantel Medical To Present At The RBC Capital Markets' 2016 Healthcare Conference
PR Newswire - Wed Feb 10, 10:49AM CST
CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, Chief Executive Officer, will be presenting at the RBC Capital Markets' 2016 Healthcare Conference at The New York Palace Hotel. The formal presentation is scheduled for Wednesday, February 24, 2016 at 9:30 a.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
CMN: 73.47 (-0.11)
Cantel Medical To Acquire NAMSA's Sterility Assurance Products Division
PR Newswire - Wed Feb 03, 6:30AM CST
CANTEL MEDICAL CORP. (NYSE: CMN), has entered into a definitive agreement with North American Science Associates, Inc. (NAMSA) to acquire NAMSA's Sterility Assurance Monitoring Products division for $13.5 million in cash consideration. For the year ending December 31, 2015 this business had adjusted sales of $5.7 million. The Sterility Assurance Monitoring Products division manufactures a broad suite of high-quality biological and chemical indicators which are used to accurately monitor the effectiveness of sterilization processes. These indicators are designed primarily for the industrial segment serving medical device, life science and other manufacturers, representing a new end-market for Cantel's Healthcare Disposables segment.
CMN: 73.47 (-0.11)
Cantel Medical Subsidiary Mar Cor Purification Releases New 2016 Online Dialysis Water Catalog
PR Newswire - Tue Jan 19, 7:30AM CST
Mar Cor Purification, a worldwide leader in water, filtration, and disinfection technologies, and the leading provider of hemodialysis water equipment in North America, recently released a new U.S. Dialysis Water Product Digital Catalog - 1st edition, available on the Mar Cor Purification website and at catalog.mcpur.com. The digital version of the catalog provides on demand U.S. list pricing for all catalog products and is designed to improve customer experience by providing faster access to information on Mar Cor dialysis products and services through a more user-friendly and interactive online experience.
CMN: 73.47 (-0.11)
Uptrend Call Working As Cantel Medical Stock Rises 18.8% (CMN)
Comtex SmarTrend(R) - Tue Dec 29, 9:39AM CST
SmarTrend identified an Uptrend for Cantel Medical (NYSE:CMN) on September 17th, 2015 at $53.37. In approximately 3 months, Cantel Medical has returned 18.77% as of today's recent price of $63.39.
CMN: 73.47 (-0.11)
